Benzothiazoles and thiazolopyridines as sirtuin modulators

Details for Australian Patent Application No. 2006278505 (hide)

Owner Sirtris Pharmaceuticals, Inc.

Inventors Xie, Roger; Ng, Pui Yee; Bemis, Jean; Salzmann, Thomas; Vu, Chi B.; Nunes, Joseph J.; Milne, Jill; Armistead, David; Disch, Jeremy S.

Agent Shelston IP

Pub. Number AU-A-2006278505

PCT Pub. Number WO2007/019346

Priority 60/792,276 14.04.06 US; 60/741,783 02.12.05 US; 60/779,370 03.03.06 US; 60/705,612 04.08.05 US

Filing date 4 August 2006

Wipo publication date 15 February 2007

International Classifications

C07D 513/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or

A61K 31/435 (2006.01) - having six-membered rings with one nitrogen as the only ring hetero atom

A61P 3/00 (2006.01) Drugs for disorders of the metabolism

A61P 7/00 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 21/00 (2006.01) Drugs for disorders of the muscular or neuromuscular system

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 27/00 (2006.01) Drugs for disorders of the senses

A61P 35/00 (2006.01) Antineoplastic agents

C07D 277/66 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

Event Publications

28 February 2008 PCT application entered the National Phase

  PCT publication WO2007/019346 Priority application(s): WO2007/019346

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006278511-Repellent materials

2006278504-Imidazopyridine derivatives as sirtuin modulating agents